Literature DB >> 26271990

Large-scale profiling of microRNAs for The Cancer Genome Atlas.

Andy Chu1, Gordon Robertson1, Denise Brooks1, Andrew J Mungall1, Inanc Birol2, Robin Coope1, Yussanne Ma1, Steven Jones3, Marco A Marra4.   

Abstract

The comprehensive multiplatform genomics data generated by The Cancer Genome Atlas (TCGA) Research Network is an enabling resource for cancer research. It includes an unprecedented amount of microRNA sequence data: ~11 000 libraries across 33 cancer types. Combined with initiatives like the National Cancer Institute Genomics Cloud Pilots, such data resources will make intensive analysis of large-scale cancer genomics data widely accessible. To support such initiatives, and to enable comparison of TCGA microRNA data to data from other projects, we describe the process that we developed and used to generate the microRNA sequence data, from library construction through to submission of data to repositories. In the context of this process, we describe the computational pipeline that we used to characterize microRNA expression across large patient cohorts.
© The Author(s) 2015. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26271990      PMCID: PMC4705681          DOI: 10.1093/nar/gkv808

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


INTRODUCTION

MicroRNAs (miRNAs) play roles in post-transcriptional regulation, but the specific roles of many miRNAs in particular genetic contexts remain poorly understood (1,2). Profiling miRNA expression using short read sequencing offers a large dynamic range and high spatial resolution, which can help generate insights into the roles of miRNAs and their regulatory targets in cancer biology. While miRNAs can now be routinely characterized on a whole transcriptome level, clarifying the functional significance of miRNAs in tumorigenesis may benefit from comparisons across subtypes within large cohorts and across tumor types. The Cancer Genome Atlas (TCGA) Research Network has generated and made publicly available comprehensive genomic data for more than 11 000 tumor samples representing 33 cancer types. The TCGA miRNA sequencing (miRNAseq) data were generated by Canada's Michael Smith Genome Sciences Centre (GSC) at the BC Cancer Agency between 2010 and 2015. This resource includes data for both tumor and adjacent normal samples, and is the largest of its type worldwide. Going forward, data from large consortia like TCGA, along with enabling initiatives like the National Cancer Institute Genomics Cloud Pilots, will create unprecedented research opportunities. Researchers will be able to interpret miRNA data from cancer cohorts in a pan-cancer context, and teams with extensive experience in the biology of particular cancers will be able to use TCGA data to complement clinical and genomics data that they generate from their own patient cohorts. To support such opportunities, here we describe the processes that we developed and used to generate the TCGA miRNAseq data. We expand on key details and in general provide more information than was previously available in the method descriptions in TCGA Research Network publications, thus providing a comprehensive reference document for those who wish to understand and use the miRNAseq data that we generated, or the computational pipeline. We describe the high-throughput transcriptome library construction protocol, the sequencing, and the data analysis pipelines that we developed for TCGA. We show that expression profiling results from our computational pipeline are similar to those from miRDeep2 (3) and ShortStack (4). However, unlike these and other miRNA analytical tools, our profiling software provides the processing method that was used to generate TCGA data, and so provides a mechanism for comparing miRNA sequencing data from other projects with this large dataset in a rigorous and consistent manner.

MATERIALS AND METHODS

Overview

Briefly, library construction was strand-specific and enriched for ∼22-bp miRNA mature strands. Libraries were pooled and then sequenced using Illumina technology. Library-specific indices added during library construction allowed assigning reads from a sequenced pool to individual samples. During analysis, the computational pipeline demultiplexed the pools and aligned the reads to a reference genome. We classified reads as miRNAs or other small RNAs (snoRNAs, tRNAs or rRNAs) by comparing read alignments to sequence feature annotations from miRBase (5) and UCSC (6); resources like Ensembl (7) can also be used. For consistency across the five years of our involvement in TCGA projects, we used miRBase v16 annotations with GRCh37/hg19 alignments and v13 annotations with GRCh36/hg18 for the earlier cancer studies. We designed the profiling pipeline to be highly specific; it reports expression only for exact-match read alignments to miRBase miRNAs and considers neither alignments with mismatches nor novel miRNAs. The raw data are isomiR sequences. We reported expression in two forms: as raw read counts and as counts normalized to reads per million mapped reads (RPM), and we submitted both forms as isomiR and stem-loop expression data archives to the TCGA data portal (https://tcga-data.nci.nih.gov/tcga/dataAccessMatrix.htm). Given this, archive downloads include four files per library: read counts and RPM, for stem-loops and isomiRs. Expression data for miRNA mature strands can be generated from the downloaded isomiR archives. The pipeline software includes scripts to collate sets of downloaded per-library files into a miRNAs-by-samples expression matrix for stem-loops, mature strands or isomiRs. For those who wish to apply other profiling pipelines, to identify novel miRNAs, or to do analyses that address sequence variants and untemplated additions, we also submitted to cgHub (https://cghub.ucsc.edu) BAM (8) files that contain exact-match, mismatch and unaligned sequence reads.

Library construction and sequencing

miRNA-seq libraries were constructed using a strand-specific, plate-based protocol developed at the GSC (Figure 1). Approximately 1 μg of either total RNA or messenger RNA-depleted RNA, containing small RNA species was used. A 3′ adapter was ligated to the RNA template using a truncated T4 RNA ligase2 (NEB Canada, cat. M0242L) with an incubation of 1 h at 22°C. This adapter was an adenylated, single-strand DNA with the sequence 5′ /5rApp/ ATCTCGTATGCCGTCTTCTGCTTGT /3ddC/, which selectively ligated miRNAs. An RNA 5′ adapter was then added, using a T4 RNA ligase (Ambion USA, cat. AM2141) and ATP, and was incubated at 37°C for 1 h. The sequence of the single strand RNA adapter is 5′GUUCAGAGUUCUACAGUCCGACGAUCUGGUCAA3′.
Figure 1.

Process used to generate TCGA miRNA sequence data. Strand-specific library construction was performed in parallel in 96-well plates. The example reference read pileup and stemloop are hsa-mir-21 from miRBase v21.

Process used to generate TCGA miRNA sequence data. Strand-specific library construction was performed in parallel in 96-well plates. The example reference read pileup and stemloop are hsa-mir-21 from miRBase v21. When ligation was completed, first strand cDNA was synthesized using Superscript II Reverse Transcriptase (Invitrogen, cat. 18064 014) and an RT primer (5′-CAAGCAGAAGACGGCATACGAGAT-3′). This was the template for the final library polymerase chain reaction (PCR), into which we introduced 6-nt index sequences that enabled libraries to be identified (i.e. demultiplexed) from a sequenced pool that contained multiple libraries. Briefly, a PCR brew mix was made with the 3′ PCR primer (5′-CAAGCAGAAGACGGCATACGAGAT-3′), Phusion Hot Start High Fidelity DNA polymerase (NEB Canada, cat. F-540L), buffer, dNTPs and dimethyl sulfoxide (DMSO). The mix was distributed evenly into a new 96-well plate. A Biomek FX (Beckman Coulter, USA) was used to transfer the PCR template (first strand cDNA) and indexed 5′ PCR primers into the brew mix plate. Each 5′ PCR primer, 5′-AATGATACGGCGACCACCGACAGNNNNNNGTTCAGAGTTCTACAGTCCGA-3′, contained a unique, fault-tolerant, 6-nt ‘index’ (shown here as N's), and was added to each well of the 96-well PCR brew plate. The hexamer index sequences enabled pooling samples for sequencing by supporting ‘demultiplexing’ the sequence data into separate sets of read sequences for each library. For TCGA, we sequenced a pool of 16 miRNA libraries in each HiSeq 2500 lane. PCR was run at 98°C for 30 s, followed by 15 cycles of 98°C for 15 s, 62°C for 30 s and 72°C for 15 s, and finally a 5 min incubation at 72°C. Quality was then checked across the whole plate using a Caliper LabChipGX DNA chip. Negative controls were added at three stages: elution buffer was added to one well when the total RNA was loaded onto the plate, water to another well just before ligating the 3′ adapter, and PCR brew mix to a final well just before PCR. PCR products were pooled, then were size selected to remove larger cDNA fragments and smaller adapter contaminants, and to enrich constructs with ∼22-bp insert lengths (Figure 1), using an automated, 96-channel size selection robot that was developed at the GSC. After size selection, each pool was ethanol precipitated, quality checked using an Agilent Bioanalyzer DNA1000 chip and quantified using a Qubit fluorometer (Invitrogen, cat. Q32854). Each pool was then diluted to a target concentration for cluster generation and loaded into a single lane of an Illumina flow cell. Clusters were generated and lanes were then sequenced using a 30-bp read to capture the miRNA sequence and a 6-bp read to capture the index sequence.

Preprocessing and aligning reads

While the size-selected miRNAs varied in length, they were typically ∼22 bp long, so were shorter than the 30-bp read length (Figure 1). Given this, each read sequence typically extended some distance into the 3′ sequencing adapter. Because this non-biological sequence could interfere with aligning reads to the reference genome, we identified and removed any 3′ adapter sequence from each read. Our adapter-trimming algorithm identified as long an adapter sequence as possible, allowing a number of mismatches that depended on the adapter length found. The algorithm first determined whether a read sequence should be discarded as an adapter dimer that had no cDNA insert by checking whether the 3′ adapter sequence occurred at the start of the read. For reads passing this stage, the algorithm then tried to identify an exact 15-bp match to the 3′ adapter sequence anywhere within the read sequence. If it could not, it tried again, starting from the 3′ end of the read sequence and allowing up to two mismatches. If the full 15 bp was not found, decreasing lengths of adapter were checked, down to the first eight bases, allowing one mismatch. If a match was still not found, from seven bases down to one base were checked, with an exact match required. Finally, the algorithm would trim one base off the 3′ end of a read if this base matched the first base of the adapter. This step was based on two considerations. First, since we only used exact match alignments for expression quantification, a trimmed sequence that gave one or more exact-match alignments was preferable to a sequence that we did not use due to a one-base mismatch. Second, if only one base of the adapter was found in the 30-nt read sequence, the read was likely too long to be from a miRNA mature strand, and the effect of the trimming on its alignment should not affect the overall miRNA profiling result for the sample from which the read was derived. Because the shortest mature miRNA in miRBase v16 is 15 bp, we discarded any trimmed read that was shorter than 15 bp. We used BWA-MEM with parameters samse -n 10 (9) to align the remaining reads to a reference genome, which, for most TCGA cancers, was GRCh37 (http://www.ncbi.nlm.nih.gov/projects/genome/assembly/grc/). This generated a SAM file (8) in which multiple alignments for a read were recorded in a single line using BWA's custom XA tag.

Profiling small RNA abundance

The pipeline assigned aligned reads to sequence features using reference databases specified by the user (Table 1), or by corresponding flat annotation files that can represent, for example, novel miRNAs that a user wishes to profile. The output was an updated SAM file in which annotations for each alignment were stored in new XC, XD and XI tags, in the order reported by the aligner in the XA tag. The advantages of writing the intermediate results into the SAM file, rather than a separate file, derive from each library having a single text file that contains both alignment and feature annotation information, has a well-documented format, and can be readily queried by scripts or from the command line. For TCGA datasets we used a 3-bp minimum overlap between an aligned read sequence and a genomic feature annotation; this minimum can be adjusted when running the profiler. For a read that had a single mapping location, but overlapped multiple types of genomic features at that location, we reduced the set of feature types to the single highest priority type, using the heuristically determined priorities in Table 1. For a multi-mapped read, we first resolved the annotation types for each alignment as we did for a uniquely mapped read, then used the priority list again to resolve the set of annotations across the multiple alignment locations into a single annotation type for that read.
Table 1.

Annotation priorities (Pr) that are used to resolve multiple annotation type matches for a single alignment location or for multiple alignment locations for a read. See ‘Profiling small RNA abundance’

PrAnnotation typeDatabase
1mature strandmiRBase
2star strand
3precursor miRNA
4stemloop, from 1 to 6 bases outside the mature strand, between the mature and star strands
5‘unannotated’, any region other than the mature strand in miRNAs where no star strand is annotated
6snoRNAUCSC small RNAs and RepeatMasker
7tRNA
8rRNA
9snRNA
10scRNA
11srpRNA
12Other RNA repeats
13coding exons with zero annotated CDS region lengthUCSC genes
143′ UTR
155′ UTR
16coding exon
17intron
18LINEUCSC RepeatMasker
19SINE
20LTR
21Satellite
22RepeatMasker DNA
23RepeatMasker low complexity
24RepeatMasker simple repeat
25RepeatMasker other
26RepeatMasker unknown
We dealt with a read that had multiple exact-match alignments to different miRNAs in one of two ways, depending on whether the read multi-mapped to mature sequences that had the same miRBase accession. A read could map to functionally identical mature miRNA strands that have identical sequences and can be expressed from different locations in the genome. For example, hsa-miR-181a-5p, whose sequence has miRBase accession ID: MIMAT0000256, occurs in both hsa-mir-181a-1 at 1q32.1 and in hsa-mir-181a-2 at 9q33.3. When we assigned a read to miR-181a-5p, we incremented the read count for this mature strand by one, while incrementing the read count by one for a random choice of one of the stem-loops hsa-mir-181a-1 or hsa-mir-181a-2. Alternatively, a read could map exactly to different miRNAs that have sequences that are similar but not identical, when the read sequence did not capture the bases that differ between these miRNAs. For such a case, we reported the read as cross-mapped (10). Supplementary Table S1 shows an example from a TCGA head-and-neck tumor library in which a 17-nt isomiR read had exact-match alignments to 22-nt 3p mature strands of both hsa-mir-30a at 6q13 and hsa-mir-30e at 1p34.2, whose sequences differ only at position 18. When a read cross-mapped, we incremented the read count by one for each miRNA to which it cross-mapped. We preserved all of its miRNA annotations and discarded all of its non-miRNA annotations, which ensured that the SAM file retained all annotation information about ambiguously mapped miRNAs, allowing the ambiguity to be addressed in downstream analysis. For each library, after aligned reads had been assigned to genomic feature annotations, the read counts for each retained annotation were summed to generate expression profiles. Reads with alignments to multiple miRNA genes were flagged as cross-mapped, and the pipeline then wrote a crossmapping report to support downstream filtering, produced graphs illustrating library content (Figure 2A and B), and generated an expression profile. When counting read annotations, reads were filtered by a set of adjustable thresholds. By default we retained reads that failed the Illumina base-calling chastity filter and excluded from expression quantification those with more than three alignments, and with mismatches or soft-clipped CIGAR strings (8); however, we retained all reads in the BAM files that we submitted to cgHub.
Figure 2.

Example library quality graphs generated by the GSC miRNA annotation profiling pipeline for thyroid carcinoma tumor libraries (1). For an individual library: (A and B) Percentage of small RNA annotations as a function of read length for two libraries. (C and D) Distribution of read lengths after adapter trimming with (C) a preferred narrower and (D) a wider insert length distribution. (E) For 496 thyroid tumor libraries, the relationship of miRNA species identified with at least 1 or 10 aligned reads versus all post-filtered (PF) reads aligned to miRNAs. The vertical red line shows the TCGA-specific threshold of 1 M reads.

Example library quality graphs generated by the GSC miRNA annotation profiling pipeline for thyroid carcinoma tumor libraries (1). For an individual library: (A and B) Percentage of small RNA annotations as a function of read length for two libraries. (C and D) Distribution of read lengths after adapter trimming with (C) a preferred narrower and (D) a wider insert length distribution. (E) For 496 thyroid tumor libraries, the relationship of miRNA species identified with at least 1 or 10 aligned reads versus all post-filtered (PF) reads aligned to miRNAs. The vertical red line shows the TCGA-specific threshold of 1 M reads.

Quality control in computational processing

The pipeline includes quality control steps before and after read alignment. After adapter trimming, a size distribution report was generated for the distribution of read lengths, which was assessed manually to ensure that size selection was successful (Figures 1, 2C and D). A narrow size distribution centered at 22 bp was typical of a good quality library, and skewed or wide distributions indicated a poor quality library or problems with size selection of library constructs. When profiling was completed, a summary report was generated that gave quality metrics that included the total number of reads aligned to miRNAs, the number of miRNA species covered by 1 and 10 reads, and a count of the total reads classified as each annotation type. To ensure that a minimum number of reads were obtained for each sample, we set a project-specific threshold from the relationship between the total number of reads that align to miRNAs and the number of miRNA species annotated. For example, for HiSeq TCGA datasets, we used a threshold of 1 M miRNA-aligned reads (Figure 2E). Finally, we used an in-house tool based on iterative principal components analysis to screen samples for lane-wise batch effects (http://www.bcgsc.ca/platform/bioinfo/software/bliss).

Consensus clustering of miRNA expression profiles

We identified potential subtypes using unsupervised Nonnegative Matrix Factorization (NMF) consensus clustering, using the CRAN R package (11). First, we removed records for miRs that had been retired by miRBase (MIRNA.dead). We ranked mature strands by variance of expression across tumor samples, then created the NMF input by selecting records for the most-variant 25% of 5p and 3p strands, corresponding to 303 v16 miRBase strands. We processed this data subset with NMF's default Brunet algorithm, surveying a range of candidate clustering solutions. We selected a preferred result by considering the profiles of the cophenetic coefficient and average silhouette widths of consensus membership matrices (12), and associations with clinical and molecular covariates, and with survival, seeking the most informative solution for the overall analysis. We generated a miR abundance heatmap for the selected clustering solution by identifying miRs that were differentially abundant between the unsupervised clusters with a SAMseq multiclass analysis in R, using the samr v2.0 R package, with a read-count input matrix and an FDR threshold of 0.05 (13). We used the pheatmap v0.7.7 R package to display the row-scaled log10(RPM + 1) abundance matrix of the 40–60 miRs that had the largest SAMseq scores and a mean tumor expression greater than 25 RPM. RPM filtering addresses potential sponge effects from competitive endogeneous RNAs (ceRNAs), which can result in weakly abundant miRs being less influential (14). Leaving samples (i.e. columns) in NMF order, we row-scaled the data matrix and clustered rows with a Euclidean distance metric. While we used (v13 or v16) miRBase MIMAT accession IDs in the isomiR data that we submitted to data repositories, for heatmaps we translated MIMATs into 5 and 3p mature strand names using a current version of miRBase. Finally, we used R to characterize associations between clusters and categorical clinical and molecular covariates by Fisher exact or Chi-square tests, and between clusters and real-valued covariates (e.g. tumor purity) by Kruskal–Wallis tests.

Comparing pipeline outputs to miRDeep2 and ShortStack

To demonstrate that results from our miRNA profiling pipeline are comparable to those from alternative pipelines, we processed FASTQ files for aligned reads for five TCGA bladder cancer miRNA-seq libraries (15) with miRDeep2 (3) and ShortStack (4). miRDeep2 and ShortStack annotate and quantify reference-aligned small RNA-seq data, and can also report putative novel miRNAs. Because we designed the TCGA pipeline to report only known miRNAs, we included only known miRNAs in the pipeline comparisons. We ran both miRDeep2 and ShortStack using default settings (Supplementary Tables S2 and S3).

RESULTS

Comparison with miRDeep2 and ShortStack

Working with FASTQ files for aligned reads for five TCGA bladder cancer datasets, we first assessed run times. Because we were quantifying only known miRNA, we constrained ShortStack to use only miRBase annotations, which reduced its run times. miRDeep2 ran in the shortest time, while ShortStack had comparable runtimes to the our TCGA pipeline (Table 2). Averaging over these five libraries, 85% of the GSC's total processing time involved BWA-MEM read alignments; post-alignment processing time was 15% of the total, with four of the five libraries requiring <0.5 h for this stage. All three tools had run times that were practical for large scale profiling, given the compute cluster resources that would typically be available to a group doing such work.
Table 2.

Average run times (h:min:s) for the five TCGA bladder cancer libraries

TCGA barcodeGSCmiRDeep2ShortStack
TCGA-G2-A2EL-01A-12R-A18B-133:00:38 (23)0:49:442:59:49
TCGA-G2-A2EK-01A-22R-A18B-133:44:41 (63)0:39:242:57:15
TCGA-FD-A3B3–01A-12R-A205–133:07:41 (27)0:29:572:58:43
TCGA-CF-A3MI-01A-11R-A20E-132:49:32 (15)0:35:443:00:05
TCGA-DK-A3IS-01A-21R-A21E-133:16:38 (25)0:49:452:59:06

The GSC and miRDeep2 pipelines were run with default settings. ShortStack was run with defaults but was constrained to miRBase v16 annotations. For GSC, numbers in parentheses are annotation times, i.e. processing time following read alignment, in minutes.

The GSC and miRDeep2 pipelines were run with default settings. ShortStack was run with defaults but was constrained to miRBase v16 annotations. For GSC, numbers in parentheses are annotation times, i.e. processing time following read alignment, in minutes. No pipeline consistently gave the smallest or largest percentage of sequence reads mapped to miRNA annotations in all libraries; our TCGA datasets reported the largest percentage in two of the libraries and miRDeep2 in three (Table 3). The miR expression profiles produced by our pipeline were highly correlated with the profiles produced by miRDeep2 (Pearson r = 0.996) and ShortStack (r = 0.988) (Table 4).
Table 3.

Percentage of reads annotated as miRNA in the five TCGA libraries

TCGA barcodeGSCmiRDeep2ShortStack
TCGA-G2-A2EL-01A-12R-A18B-1331.037.829.5
TCGA-G2-A2EK-01A-22R-A18B-1332.648.844.3
TCGA-FD-A3B3–01A-12R-A205–1352.560.456.2
TCGA-CF-A3MI-01A-11R-A20E-1340.035.732.0
TCGA-DK-A3IS-01A-21R-A21E-1358.254.646.3

Bold text marks the maximum percentage for the three methods for a library.

Table 4.

Pearson correlation coefficients for normalized miR abundance profiles generated by the three annotation methods for five TCGA libraries

All miRsmiRs with ≥10 reads
GSCGSCMDGSCGSCMD
TCGA barcodeMDSSSSMDSSSSS
TCGA-G2-A2EL-01A-12R-A18B-130.9980.9750.9810.9980.9750.981
TCGA-G2-A2EK-01A-22R-A18B-130.9980.9971.0000.9980.9971.000
TCGA-FD-A3B3–01A-12R-A205–130.9980.9971.0000.9980.9971.000
TCGA-CF-A3MI-01A-11R-A20E-130.9980.9960.9990.9980.9960.999
TCGA-DK-A3IS-01A-21R-A21E-130.9900.9760.9940.9890.9750.994

Per-sample miR profiles were normalized to reads per 1 M miR-annotated reads (RPM). MD: miRDeep2. SS: ShortStack

Bold text marks the maximum percentage for the three methods for a library. Per-sample miR profiles were normalized to reads per 1 M miR-annotated reads (RPM). MD: miRDeep2. SS: ShortStack Our miRNA species were highly concordant with those from the other two pipelines (Figure 3, Table 5); across the five test libraries, an average of 99.5% of the miRs that our profiler annotated as having nonzero read support were concordant with miRs annotated by the other two pipelines. Corresponding averages for ShortStack and miRDeep2 were 98.1 and 95.6%. We noted that the miRs detected by only one or two of the methods were largely those with low abundance (Tables 6 and 7), which are less likely to be biologically influential than more abundant miRs (14). Only six miRs, and all with relatively low abundance, were identified by both miRDeep2 and ShortStack in all of the five samples that were not reported as expressed in our TCGA results (Table 8). While our profiler annotated reads for all of these miRs, we did not retain them for the archives submitted to the TCGA repositories because the alignments did not pass our filters, which required an exact read alignment to a known miRNA, with three or fewer multiple mappings to the reference genome. When we relaxed these filters to allow any number of ambiguous mappings with up to one base mismatch, our profiler mapped reads to each of these miRs in at least one sample.
Figure 3.

Venn diagram of miRNAs detected at any level of read coverage, in at least one of the five bladder cancer libraries, by the GSC, miRDeep2 (MD) and ShortStack (SS). (A) All methods were run with default settings. (B) The GSC pipeline was run with lowered quality settings that allowed multimapping and one mismatch. miRs detected by only one or two methods had low RPMs. See Tables 6 and 7.

Table 5.

Number of miRNA species to which reads were mapped using miRBase v16 (of 1222 possible mature miRs)

GSCmiRDeep2ShortStack
TCGA barcodeTotal>10 readsTotal>10 readsTotal>10 reads
TCGA-G2-A2EL-01A-12R-A18B-13648429719485687461
TCGA-G2-A2EK-01A-22R-A18B-13638421699466680437
TCGA-FD-A3B3–01A-12R-A205–13612365676404658385
TCGA-CF-A3MI-01A-11R-A20E-13575323629363614348
TCGA-DK-A3IS-01A-21R-A21E-13650426697473689445

In a library with 1 M miR-aligned reads, 10 reads corresponds to 1e-5 RPM.

Table 6.

The number and normalized abundance (RPM) for miRNA species reported by the GSC, MiRDeep2 and Shortstack profiling pipelines, using default settings

GSC RPMMiRDeep2 RPMShortstack RPM
Venn MembershipTotal miRsMedian (mean)MaxMedian (mean)MaxMedian (mean)Max
All pipelines7853.0 (1045)223 3162.1 (1044)345 0353.18 (1274)378 133
GSC and MD120.05 (0.09)0.380.02 (0.03)0.14
GSC and SS180.14 (0.57)7.10.17 (0.62)7.4
MD and SS490.17 (3.96)113.90.07 (0.77)13.7
Only SS190.04 (3.01)42.4
Only MD300.06 (0.16)1.1
Only GSC40.04 (0.04)0.08
Grand Total917

See Figure 3, compare to Table 7. MD: miRDeep2. SS: ShortStack

Table 7.

The number and normalized abundance (RPM) for miRNA species reported by GSC, MiRDeep2 and Shortstack profiling pipelines, relaxing settings for GSC to allow up to one base mismatch and any number of mapping locations

GSC RPMMiRDeep2 RPMShortStack RPM
Venn membershipTotal miRsMedian (mean)MaxMedian (mean)MaxMedian (mean)Max
All pipelines8332.85 (1201)273 8273.44 (1201)354 2652.91 (1201)378 133
GSC and MD250.17 (0.27)1.900.17 (0.42)3.07
GSC and SS250.17 (0.40)4.600.32 (0.62)7.4
MD and SS10.79 (0.79)0.790.22 (0.22)0.22
Only SS120.21 (4.85)42.4
Only MD170.28 (0.35)1.1
Only GSC380.14 (0.15)0.34
Grand Total951
Table 8.

Average RPM of miRs found by both miRDeep and Shortstack in all five samples and were not counted as annotated by the GSC

MIMATmiR namemiRBase sequencemiRDeep2 Mean RPMShortstack Mean RPM
MIMAT0005911miR-1260AUCCCACCUCUGCCACCA17.341.86
MIMAT0005927miR-1274aGUCCCUGUUCAGGCGCCA0.270.09
MIMAT0005946miR-1280UCCCACCGCUGCCACCC0.610.14
MIMAT0005450miR-518e-5pCUCUAGAGGGAAGCGCUUUCUG0.430.06
MIMAT0002831miR-519c-5pCUCUAGAGGGAAGCGCUUUCUG0.430.06
MIMAT0004984miR-941CACCCGGCUGUGUGCACAUGUGC0.920.09
Venn diagram of miRNAs detected at any level of read coverage, in at least one of the five bladder cancer libraries, by the GSC, miRDeep2 (MD) and ShortStack (SS). (A) All methods were run with default settings. (B) The GSC pipeline was run with lowered quality settings that allowed multimapping and one mismatch. miRs detected by only one or two methods had low RPMs. See Tables 6 and 7. In a library with 1 M miR-aligned reads, 10 reads corresponds to 1e-5 RPM. See Figure 3, compare to Table 7. MD: miRDeep2. SS: ShortStack

DISCUSSION

To support resource-intensive analysis of comprehensive cancer genomics data, and to enable the comparison of microRNA sequencing data from other projects to TCGA data, we have described the process that we developed and used to generate miRNA sequencing datasets for TCGA, and the computational pipeline with which we characterized miRNA expression. In order that readers have access to a more detailed description of the nature of the TCGA miRNA data, which emphasizes mature strands and isomiRs, we have expanded on material that has been published in Methods sections in TCGA marker papers, and describe the pipeline in the context of the overall data generation process. We designed the process for high-throughput processing across large cohorts, specificity for known miRNAs, and for stability and comparability across a multi-year project. Since we initially implemented the pipeline in 2009, we have developed library and computational processes, and automation, increasing our processing capacity by 10-fold, from several hundred samples per year to several thousand per year. We have used the production system to analyze human and mouse sequence data in projects involving as few as three samples, to projects as large as TCGA, for which, to date, we processed 11 506 miRNA samples and submitted sequence data for 11 259 samples across 33 cancer types. We have also analyzed 4049 miRNA sequencing libraries in other projects. The TCGA data that we generated have contributed to a number of publications (15–25), and are contributing to over ten TCGA projects that are underway at the time of writing. While we focus here on applying the pipeline to large-scale cancer datasets in the context of TCGA, the modular pipeline can run on any SAM-format read alignment file generated for any species that has a reference genome and annotated miRNAs, accessing annotations from a database or from user-created text files. The profiling software is freely available to enable rigorous and consistent comparisons to TCGA data.

AVAILABILITY

The profiling pipeline runs on Linux and Unix-like systems and is available at: http://www.bcgsc.ca/platform/bioinfo/software/mirna-profiling, and the adapter trimming software at: http://www.bcgsc.ca/platform/bioinfo/software/adapter-trimming-for-small-rna-sequencing.

SUPPLEMENTARY DATA

Supplementary Data are available at NAR Online.
  25 in total

1.  Cross-mapping and the identification of editing sites in mature microRNAs in high-throughput sequencing libraries.

Authors:  Michiel J L de Hoon; Ryan J Taft; Takehiro Hashimoto; Mutsumi Kanamori-Katayama; Hideya Kawaji; Mitsuoki Kawano; Mami Kishima; Timo Lassmann; Geoffrey J Faulkner; John S Mattick; Carsten O Daub; Piero Carninci; Jun Kawai; Harukazu Suzuki; Yoshihide Hayashizaki
Journal:  Genome Res       Date:  2010-01-05       Impact factor: 9.043

Review 2.  Identification and consequences of miRNA-target interactions--beyond repression of gene expression.

Authors:  Jean Hausser; Mihaela Zavolan
Journal:  Nat Rev Genet       Date:  2014-07-15       Impact factor: 53.242

3.  The Sequence Alignment/Map format and SAMtools.

Authors:  Heng Li; Bob Handsaker; Alec Wysoker; Tim Fennell; Jue Ruan; Nils Homer; Gabor Marth; Goncalo Abecasis; Richard Durbin
Journal:  Bioinformatics       Date:  2009-06-08       Impact factor: 6.937

4.  Discovering microRNAs from deep sequencing data using miRDeep.

Authors:  Marc R Friedländer; Wei Chen; Catherine Adamidi; Jonas Maaskola; Ralf Einspanier; Signe Knespel; Nikolaus Rajewsky
Journal:  Nat Biotechnol       Date:  2008-04       Impact factor: 54.908

5.  Silhouette scores for assessment of SNP genotype clusters.

Authors:  Lovisa Lovmar; Annika Ahlford; Mats Jonsson; Ann-Christine Syvänen
Journal:  BMC Genomics       Date:  2005-03-10       Impact factor: 3.969

6.  The UCSC Genome Browser database: 2015 update.

Authors:  Kate R Rosenbloom; Joel Armstrong; Galt P Barber; Jonathan Casper; Hiram Clawson; Mark Diekhans; Timothy R Dreszer; Pauline A Fujita; Luvina Guruvadoo; Maximilian Haeussler; Rachel A Harte; Steve Heitner; Glenn Hickey; Angie S Hinrichs; Robert Hubley; Donna Karolchik; Katrina Learned; Brian T Lee; Chin H Li; Karen H Miga; Ngan Nguyen; Benedict Paten; Brian J Raney; Arian F A Smit; Matthew L Speir; Ann S Zweig; David Haussler; Robert M Kuhn; W James Kent
Journal:  Nucleic Acids Res       Date:  2014-11-26       Impact factor: 19.160

7.  Comprehensive genomic characterization of head and neck squamous cell carcinomas.

Authors: 
Journal:  Nature       Date:  2015-01-29       Impact factor: 49.962

8.  Ensembl 2015.

Authors:  Fiona Cunningham; M Ridwan Amode; Daniel Barrell; Kathryn Beal; Konstantinos Billis; Simon Brent; Denise Carvalho-Silva; Peter Clapham; Guy Coates; Stephen Fitzgerald; Laurent Gil; Carlos García Girón; Leo Gordon; Thibaut Hourlier; Sarah E Hunt; Sophie H Janacek; Nathan Johnson; Thomas Juettemann; Andreas K Kähäri; Stephen Keenan; Fergal J Martin; Thomas Maurel; William McLaren; Daniel N Murphy; Rishi Nag; Bert Overduin; Anne Parker; Mateus Patricio; Emily Perry; Miguel Pignatelli; Harpreet Singh Riat; Daniel Sheppard; Kieron Taylor; Anja Thormann; Alessandro Vullo; Steven P Wilder; Amonida Zadissa; Bronwen L Aken; Ewan Birney; Jennifer Harrow; Rhoda Kinsella; Matthieu Muffato; Magali Ruffier; Stephen M J Searle; Giulietta Spudich; Stephen J Trevanion; Andy Yates; Daniel R Zerbino; Paul Flicek
Journal:  Nucleic Acids Res       Date:  2014-10-28       Impact factor: 16.971

9.  Fast and accurate short read alignment with Burrows-Wheeler transform.

Authors:  Heng Li; Richard Durbin
Journal:  Bioinformatics       Date:  2009-05-18       Impact factor: 6.937

10.  Comprehensive molecular characterization of gastric adenocarcinoma.

Authors: 
Journal:  Nature       Date:  2014-07-23       Impact factor: 49.962

View more
  65 in total

Review 1.  Small non-coding RNAs in human cancer: function, clinical utility, and characterization.

Authors:  Zhao Zhang; Jian Zhang; Lixia Diao; Leng Han
Journal:  Oncogene       Date:  2021-01-15       Impact factor: 9.867

Review 2.  A network-biology perspective of microRNA function and dysfunction in cancer.

Authors:  Cameron P Bracken; Hamish S Scott; Gregory J Goodall
Journal:  Nat Rev Genet       Date:  2016-10-31       Impact factor: 53.242

3.  Findings from the Section on Bioinformatics and Translational Informatics.

Authors:  H Dauchel; T Lecroq
Journal:  Yearb Med Inform       Date:  2016-11-10

4.  Translational Opportunities for Microfluidic Technologies to Enable Precision Epigenomics.

Authors:  Yi Xu; Steven R Doonan; Tamas Ordog; Ryan C Bailey
Journal:  Anal Chem       Date:  2020-06-04       Impact factor: 6.986

5.  Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma.

Authors: 
Journal:  Cancer Cell       Date:  2017-08-14       Impact factor: 31.743

6.  The Integrated Genomic Landscape of Thymic Epithelial Tumors.

Authors:  Milan Radovich; Curtis R Pickering; Ina Felau; Gavin Ha; Hailei Zhang; Heejoon Jo; Katherine A Hoadley; Pavana Anur; Jiexin Zhang; Mike McLellan; Reanne Bowlby; Thomas Matthew; Ludmila Danilova; Apurva M Hegde; Jaegil Kim; Mark D M Leiserson; Geetika Sethi; Charles Lu; Michael Ryan; Xiaoping Su; Andrew D Cherniack; Gordon Robertson; Rehan Akbani; Paul Spellman; John N Weinstein; D Neil Hayes; Ben Raphael; Tara Lichtenberg; Kristen Leraas; Jean Claude Zenklusen; Junya Fujimoto; Cristovam Scapulatempo-Neto; Andre L Moreira; David Hwang; James Huang; Mirella Marino; Robert Korst; Giuseppe Giaccone; Yesim Gokmen-Polar; Sunil Badve; Arun Rajan; Philipp Ströbel; Nicolas Girard; Ming S Tsao; Alexander Marx; Anne S Tsao; Patrick J Loehrer
Journal:  Cancer Cell       Date:  2018-02-12       Impact factor: 31.743

7.  Identifying microRNA panels specifically associated with hepatocellular carcinoma and its different etiologies.

Authors:  Jing Shen; Abby B Siegel; Helen Remotti; Qiao Wang; Regina M Santella
Journal:  Hepatoma Res       Date:  2016-06-01

8.  Proteogenomic Characterization of Endometrial Carcinoma.

Authors:  Yongchao Dou; Emily A Kawaler; Daniel Cui Zhou; Marina A Gritsenko; Chen Huang; Lili Blumenberg; Alla Karpova; Vladislav A Petyuk; Sara R Savage; Shankha Satpathy; Wenke Liu; Yige Wu; Chia-Feng Tsai; Bo Wen; Zhi Li; Song Cao; Jamie Moon; Zhiao Shi; MacIntosh Cornwell; Matthew A Wyczalkowski; Rosalie K Chu; Suhas Vasaikar; Hua Zhou; Qingsong Gao; Ronald J Moore; Kai Li; Sunantha Sethuraman; Matthew E Monroe; Rui Zhao; David Heiman; Karsten Krug; Karl Clauser; Ramani Kothadia; Yosef Maruvka; Alexander R Pico; Amanda E Oliphant; Emily L Hoskins; Samuel L Pugh; Sean J I Beecroft; David W Adams; Jonathan C Jarman; Andy Kong; Hui-Yin Chang; Boris Reva; Yuxing Liao; Dmitry Rykunov; Antonio Colaprico; Xi Steven Chen; Andrzej Czekański; Marcin Jędryka; Rafał Matkowski; Maciej Wiznerowicz; Tara Hiltke; Emily Boja; Christopher R Kinsinger; Mehdi Mesri; Ana I Robles; Henry Rodriguez; David Mutch; Katherine Fuh; Matthew J Ellis; Deborah DeLair; Mathangi Thiagarajan; D R Mani; Gad Getz; Michael Noble; Alexey I Nesvizhskii; Pei Wang; Matthew L Anderson; Douglas A Levine; Richard D Smith; Samuel H Payne; Kelly V Ruggles; Karin D Rodland; Li Ding; Bing Zhang; Tao Liu; David Fenyö
Journal:  Cell       Date:  2020-02-13       Impact factor: 41.582

9.  miR-221 Targets QKI to Enhance the Tumorigenic Capacity of Human Colorectal Cancer Stem Cells.

Authors:  Junko Mukohyama; Taichi Isobe; Qingjiang Hu; Takanori Hayashi; Takashi Watanabe; Masao Maeda; Hisano Yanagi; Xin Qian; Kimihiro Yamashita; Hironobu Minami; Koshi Mimori; Debashis Sahoo; Yoshihiro Kakeji; Akira Suzuki; Piero Dalerba; Yohei Shimono
Journal:  Cancer Res       Date:  2019-08-15       Impact factor: 12.701

10.  Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.

Authors:  A Gordon Robertson; Jaegil Kim; Hikmat Al-Ahmadie; Joaquim Bellmunt; Guangwu Guo; Andrew D Cherniack; Toshinori Hinoue; Peter W Laird; Katherine A Hoadley; Rehan Akbani; Mauro A A Castro; Ewan A Gibb; Rupa S Kanchi; Dmitry A Gordenin; Sachet A Shukla; Francisco Sanchez-Vega; Donna E Hansel; Bogdan A Czerniak; Victor E Reuter; Xiaoping Su; Benilton de Sa Carvalho; Vinicius S Chagas; Karen L Mungall; Sara Sadeghi; Chandra Sekhar Pedamallu; Yiling Lu; Leszek J Klimczak; Jiexin Zhang; Caleb Choo; Akinyemi I Ojesina; Susan Bullman; Kristen M Leraas; Tara M Lichtenberg; Catherine J Wu; Nicholaus Schultz; Gad Getz; Matthew Meyerson; Gordon B Mills; David J McConkey; John N Weinstein; David J Kwiatkowski; Seth P Lerner
Journal:  Cell       Date:  2017-10-05       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.